Intercept Reports Phase III Sub-Study Liver Biopsy Data
Intercept (ICPT) announces data from the POISE biopsy sub-study which showed that treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patien.....»»
Intercept announces data from liver biopsy substudy of POISE Phase 3 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aptinyx reports "positive" data from Phase 2 study of NYX-783
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Turning Point reports Phase 1/2 SWORD-1 study data of TPX-0046
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BrainStorm reports "positive" data in Phase 2 study evaluating NurOwn
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Epizyme reports preliminary data from Phase 1b/3 study of EZH-302
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma announces data from the Phase II advanced liver cancer study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Denali Therapeutics reports three-month data from Phase 1/2 study of ETV:IDS
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seneca Biopharma reports data from Phase 2 study of NSI-566 in China
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Provention Bio reports "positive" data from Phase 1b PREVAIL study of PRV-3279
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Completed enrollment for the pivotal REST-ON Phase 3 study in Q4 2019; data readout expected in Q2 2020 Raised $65 million in gross proceeds from privat.....»»
Xeris Pharmaceuticals reports "positive" phase 2 data in glucagon study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Achillion reports "positive" data from Phase 2 danicopan, eculizumab study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TG Therapeutics reports triple therapy data from Phase I/II study of ublitux
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam initiates Phase 3 study of lumasiran, reports "positive" Phase 2 data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immutep reports efficacy data for TACTI-mel Phase 1 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aravive reports data from Phase 1b/2 study of AVB-500 in ovarian cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xynomic reports interim data from Phase 1b study of abexinostat w/ Keytruda
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress
- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemph.....»»